About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $59.89 | Open | $61.61 |
| Volume | 7.68M | Market Cap | 7.07B |
| Yield | Last Dividend |
| Ex-FDA Chief On White House's Coronaviru... | 10:02 AM |
| The Trump administration is prioritizing five COVID-19 vaccine programs, but ex-FDA chief Dr. Scott Gottlieb said the White House needs to spread its ... | |
| Morning Bell With Jim Cramer: Amazon, Bo... | 7:49 AM |
| Jim Cramer shares stock market news including Amazon coming after small businesses, Boeing 737 Max being ready and Regeneron or Moderna as the vaccine... | |
| David Meline Joins Moderna as Chief Fina... | 7:00 AM |
| CAMBRIDGE, Mass.--(BUSINESS WIRE)--David Meline joins Moderna as Chief Financial Officer. | |
| Fauci offers an optimistic timeline for ... | 06/03/20 |
| Anthony Fauci said this week that hundreds of millions of coronavirus vaccine doses could be ready by early 2021. Moderna will begin testing its vacci... | |
| Watchdog urges SEC to investigate vaccin... | 06/03/20 |
| Accountable.US told the agency that Moderna executives "exploited coronavirus fears" to boost their own stock wealth. | |
| Here are the 5 coronavirus vaccine progr... | 06/03/20 |
| The Trump administration has selected five top coronavirus vaccine programs, the New York Times reported Wednesday . In the race for an effective vacc... | |
| White House Picks 5 'Finalists' For Vacc... | 06/03/20 |
| White House Picks 5 'Finalists' For Vaccine Candidate Trials Tyler Durden Wed, 06/03/2020 - 13:28 Despite a paucity of scientific evidence that has pr... | |
| Fauci just confirmed the bad coronavirus... | 06/03/20 |
| Dr. Anthony Fauci made new coronavirus vaccine comments addressing coronavirus immunity concerns. The expert said that the drugs that are in developme... | |
| US-based Moderna begins phase 2 human tr... | 06/03/20 |
| New York, June 3 (IANS) In a ray of hope against Covid-19, Massachusetts-based biotechnology giant Moderna has commenced stage 2 trials for its new co... | |
| Fauci is 'optimistic' Moderna's coronavi... | 06/02/20 |
| America's top infectious disease expert, Dr Anthony Fauci, said he is 'cautiously optimistic' that one of several coronavirus vaccines being developed... | |
| Fauci just criticized vaccine maker Mode... | 06/02/20 |
| The first novel coronavirus vaccine that reached human trials in the US comes from Moderna. It's an mRNA drug that shows promise, according to an anno... | |
| Moderna (MRNA) Stock Falls 7%, Company S... | 06/02/20 |
| Moderna (MRNA) stock price has lost arounf 7% today despite the fact that Moderna announced that it had begun its phase-2 trials. | |
| Moderna Highlights Advances in Platform ... | 06/02/20 |
| CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna highlights advances in platform science and innovative vaccine research at third annual Science Day. | |
| Note To Rioting Americans: Why Looting A... | 06/01/20 |
| Note To Rioting Americans: Why Looting A Rolex Store Isn't Such A Great Idea Tyler Durden Mon, 06/01/2020 - 19:10 As SJW blue-checks pressure Twitter ... | |
| Moderna launches second phase trial for ... | 06/01/20 |
| On Friday, Moderna dosed the first participants in a trial to test whether its coronavirus shot can block infection, but experts have questioned the m... | |
| Moderna (MRNA) Shares Up 0.37% amid Conc... | 06/01/20 |
| Moderna (MRNA) shares price us slightly up despite investors' concerns about stock sales. The stock has lost around $20 from its ATH. | |
| Fauci just criticized Moderna for toutin... | 06/01/20 |
| Several companies have been racing to develop a vaccine for the novel coronavirus, and research efforts are moving faster than ever before. Moderna, w... | |
| Moderna Doses First Participants In Phas... | 06/01/20 |
| Moderna Inc (NASDAQ: MRNA ) announced late Friday it has dosed the first participants in a Phase 2 trial of its mRNA vaccine, codenamed mRNA-1273, aga... | |
| Moderna???s Covid-19 Vaccine Enters Next... | 06/01/20 |
| The biotech company Moderna has dosed the first volunteers in the next phase of testing for its vaccine against the Covid-19 virus. | |
| The race for coronavirus treatments and ... | 06/01/20 |
| The race for coronavirus treatments and vaccines is expected to maintain its frenetic pace in June. Business Insider identified the 12 top events to w... | |
| Moderna's coronavirus vaccine announceme... | 06/01/20 |
| Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary results from its coronavirus vaccine trial. As the ... | |
| One vaccine maker is thinking about inte... | 05/31/20 |
| Coronavirus vaccine trials have hit a serious snag, as there aren???t enough COVID-19 patients in the communities where volunteers might reside. If no... | |
| Coronavirus (Covid-19) vaccine latest up... | 05/31/20 |
| Coronavirus, Covid-19 Vaccine Latest News Update Today: Sinovac Biotech says it is 99 percent sure of its CoronaVac vaccine efficacy; Patanjali group ... | |
| Another coronavirus vaccine candidate mi... | 05/30/20 |
| Another potential coronavirus vaccine might be available this fall. Pfizer said the candidate it???s developing with BioNTech could be ready by Octobe... | |
| Firm behind coronavirus vaccine candidat... | 05/30/20 |
| The American biotech firm leading the way in the development of a Covid-19 vaccine has been accused of trying to boost its share price and an ???appal... | |
| Coronavirus: Moderna starts dosing patie... | 05/29/20 |
| Moderna Inc said on Friday it had started dosing patients in a mid-stage study with its experimental coronavirus vaccine and eventually plans to enrol... | |
| Live: Human trials of coronavirus vaccin... | 05/29/20 |
| Human trials of a coronavirus vaccine have expanded, with US company Moderna saying it has started giving patients doses of its experimental vaccine. ... | |
| Moderna Announces First Participants in ... | 05/29/20 |
| CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna announces first participants in each age cohort dosed in Phase 2 Study of mRNA vaccine (mRNA-1273) against ... | |
| Chasing a virus, glass shortages, and co... | 05/28/20 |
| A coronavirus vaccine faces several major challenges to actually end the pandemic, top pharmaceutical executives said Thursday. Execs for four major p... | |
| Moderna Expands Deal With CDMO To Source... | 05/28/20 |
| Moderna Inc (NASDAQ: MRNA ) is progressing rapidly in its program to develop an mRNA vaccine for SARS-CoV-2, codenamed mRNA-1273. What Happened The Lu... | |
| Strong Buy rating | 05/20/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $37.00 to $90.00 | |
| Strong Buy rating | 05/19/20 |
| BMO Capital maintains Outperform rating and raises Price Target from $83.00 to $112.00 | |
| Hold rating | 05/19/20 |
| B of A Securities maintains Neutral rating and raises Price Target from $70.00 to $95.00 | |
| Buy rating | 05/18/20 |
| Goldman Sachs maintains Buy rating and raises Price Target from $63.00 to $105.00 | |
| Buy rating | 05/07/20 |
| Needham maintains Buy rating and raises Price Target from $35.00 to $58.00 | |
| Strong Buy rating | 04/30/20 |
| BMO Capital initiates coverage with Outperform rating and announces Price Target of $83.00 | |
| Buy rating | 04/28/20 |
| Chardan Capital maintains Buy rating and raises Price Target from $40.00 to $52.00 | |
| Strong Buy rating | 04/15/20 |
| Oppenheimer maintains Outperform rating and raises Price Target from $31.00 to $43.00 | |
| Strong Buy rating | 04/15/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $30.00 to $37.00 | |
| Date | 2020-05-07 (BMO) | Est. (EPS/Rev.) | ($0.35)/ 17.09M |
| Actual (EPS/Rev.) | $-0.35/ $8.39 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Profit Tags Stock Hoot Plan | Mitt M | 100.00 % | Subscribe |
| Stock_Options | alps | 93.00 % | Follow |
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| Value Investing | BigMoveTrader | 59.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.